These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 25887157)

  • 1. Celf1 regulates cell cycle and is partially responsible for defective myoblast differentiation in myotonic dystrophy RNA toxicity.
    Peng X; Shen X; Chen X; Liang R; Azares AR; Liu Y
    Biochim Biophys Acta; 2015 Jul; 1852(7):1490-7. PubMed ID: 25887157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mir-206 partially rescues myogenesis deficiency by inhibiting CUGBP1 accumulation in the cell models of myotonic dystrophy.
    Dong W; Chen X; Wang M; Zheng Z; Zhang X; Xiao Q; Peng X
    Neurol Res; 2019 Jan; 41(1):9-18. PubMed ID: 30281408
    [No Abstract]   [Full Text] [Related]  

  • 3. Elevation of RNA-binding protein CUGBP1 is an early event in an inducible heart-specific mouse model of myotonic dystrophy.
    Wang GS; Kearney DL; De Biasi M; Taffet G; Cooper TA
    J Clin Invest; 2007 Oct; 117(10):2802-11. PubMed ID: 17823658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MBNL1 and CUGBP1 modify expanded CUG-induced toxicity in a Drosophila model of myotonic dystrophy type 1.
    de Haro M; Al-Ramahi I; De Gouyon B; Ukani L; Rosa A; Faustino NA; Ashizawa T; Cooper TA; Botas J
    Hum Mol Genet; 2006 Jul; 15(13):2138-45. PubMed ID: 16723374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In silico discovery of substituted pyrido[2,3-d]pyrimidines and pentamidine-like compounds with biological activity in myotonic dystrophy models.
    González ÀL; Konieczny P; Llamusi B; Delgado-Pinar E; Borrell JI; Teixidó J; García-España E; Pérez-Alonso M; Estrada-Tejedor R; Artero R
    PLoS One; 2017; 12(6):e0178931. PubMed ID: 28582438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-322/-503 rescues myoblast defects in myotonic dystrophy type 1 cell model by targeting CUG repeats.
    Shen X; Xu F; Li M; Wu S; Zhang J; Wang A; Xu L; Liu Y; Zhu G
    Cell Death Dis; 2020 Oct; 11(10):891. PubMed ID: 33093470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of MBNL1-mediated retrograde BDNF signaling in the myotonic dystrophy brain.
    Wang PY; Kuo TY; Wang LH; Liang WH; Wang GS
    Acta Neuropathol Commun; 2023 Mar; 11(1):44. PubMed ID: 36922901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small molecule kinase inhibitors alleviate different molecular features of myotonic dystrophy type 1.
    Wojciechowska M; Taylor K; Sobczak K; Napierala M; Krzyzosiak WJ
    RNA Biol; 2014; 11(6):742-54. PubMed ID: 24824895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-322/miR-503 clusters regulate defective myoblast differentiation in myotonic dystrophy RNA-toxic by targeting Celf1.
    Dong W; Liu Q; Wang ZC; Du XX; Liu LL; Wang N; Weng JF; Peng XP
    Toxicol Res (Camb); 2021 Jan; 10(1):29-39. PubMed ID: 33613970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytoplasmic CUG RNA foci are insufficient to elicit key DM1 features.
    Dansithong W; Wolf CM; Sarkar P; Paul S; Chiang A; Holt I; Morris GE; Branco D; Sherwood MC; Comai L; Berul CI; Reddy S
    PLoS One; 2008; 3(12):e3968. PubMed ID: 19092997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MBNL1 is the primary determinant of focus formation and aberrant insulin receptor splicing in DM1.
    Dansithong W; Paul S; Comai L; Reddy S
    J Biol Chem; 2005 Feb; 280(7):5773-80. PubMed ID: 15546872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correction of RNA-Binding Protein CUGBP1 and GSK3β Signaling as Therapeutic Approach for Congenital and Adult Myotonic Dystrophy Type 1.
    Timchenko L
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31877772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction of Glycogen Synthase Kinase 3β in Myotonic Dystrophy 1 Reduces the Mutant RNA and Improves Postnatal Survival of DMSXL Mice.
    Wang M; Weng WC; Stock L; Lindquist D; Martinez A; Gourdon G; Timchenko N; Snape M; Timchenko L
    Mol Cell Biol; 2019 Nov; 39(21):. PubMed ID: 31383751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (CTG)n repeat-mediated dysregulation of MBNL1 and MBNL2 expression during myogenesis in DM1 occurs already at the myoblast stage.
    André LM; van Cruchten RTP; Willemse M; Wansink DG
    PLoS One; 2019; 14(5):e0217317. PubMed ID: 31116797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced cytoplasmic MBNL1 is an early event in a brain-specific mouse model of myotonic dystrophy.
    Wang PY; Lin YM; Wang LH; Kuo TY; Cheng SJ; Wang GS
    Hum Mol Genet; 2017 Jun; 26(12):2247-2257. PubMed ID: 28369378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered phosphorylation and intracellular distribution of a (CUG)n triplet repeat RNA-binding protein in patients with myotonic dystrophy and in myotonin protein kinase knockout mice.
    Roberts R; Timchenko NA; Miller JW; Reddy S; Caskey CT; Swanson MS; Timchenko LT
    Proc Natl Acad Sci U S A; 1997 Nov; 94(24):13221-6. PubMed ID: 9371827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the effects of CELF1 deficiency in a mouse model of RNA toxicity.
    Kim YK; Mandal M; Yadava RS; Paillard L; Mahadevan MS
    Hum Mol Genet; 2014 Jan; 23(2):293-302. PubMed ID: 24001600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A low absolute number of expanded transcripts is involved in myotonic dystrophy type 1 manifestation in muscle.
    Gudde AE; González-Barriga A; van den Broek WJ; Wieringa B; Wansink DG
    Hum Mol Genet; 2016 Apr; 25(8):1648-62. PubMed ID: 26908607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age of onset of RNA toxicity influences phenotypic severity: evidence from an inducible mouse model of myotonic dystrophy (DM1).
    Gladman JT; Mandal M; Srinivasan V; Mahadevan MS
    PLoS One; 2013; 8(9):e72907. PubMed ID: 24039817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bruno-3 regulates sarcomere component expression and contributes to muscle phenotypes of myotonic dystrophy type 1.
    Picchio L; Legagneux V; Deschamps S; Renaud Y; Chauveau S; Paillard L; Jagla K
    Dis Model Mech; 2018 May; 11(5):. PubMed ID: 29716962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.